IFNG and common variable immunodeficiency: One of the earliest studies that prospectively evaluated the cellular immune response to the SARS-CoV-2 vaccine studied S-specific IFNγ T cell response by FluoroSpot in 18 patients with CVID before and after the 2nd dose of the SARS-CoV-2 vaccines.